MedShr Logo

Gamechanger for medical research – MedShr launches Docsearch

21 September, 2022

MedShr is excited to launch MedShr docsearch, an AI-driven platform that analyses published medical evidence and rapidly reviews complex scientific literature. This technology is being put in the hands of clinicians and academics for the first time, exclusively through MedShr.

Described as a game changer for medical research and clinical practice, MedShr docsearch saves hours of research time, explores data in new ways and can improve patient care. The analytical dashboard shows trending concepts, influential authors, clinical trial status and much more. 

Putting Knowledge into the Hands of Physicians 

MedShr docsearch leverages custom technology developed by Dr. Evidence for drug discovery and pharmaceutical research. For the first time, our exclusive partnership puts this knowledge in the hands of physicians around the world.

The partnership integrates Dr.Evidence’s AI-powered medical search engine with the MedShr platform for physicians, HCPs, medical societies, and academics. 

“We are excited about the power that DocSearch puts in the hands of physicians to engage with the published evidence. The real-time AI insights and analysis from MedShr docsearch combined with MedShr case discussion and peer-to-peer learning will have a tremendous impact on clinical practice and patient care,” said MedShr Founder and CEO Asif Qasim, MA PhD FRCP.  

Better Patient Outcomes 

When you type a query into MedShr docsearch, the tool utilizes its powerful natural language processing and machine learning technology to generate evidence-based results within seconds. 

This means physicians and HCPs will no longer have to spend hours using multiple search engines and tools to get the type of analysis possible in MedShr docsearch. With over 40 million biomedical citations, 108 million biomedical relationships and 4.9 million medical concepts, MedShr docsearch turbocharges any PubMed search. Clinicians will be able to better understand published data, from disease symptoms to drug-adverse events, and beyond. The insights will inform and transform interventions for better patient health outcomes. 

“Since the beginning, our vision has been to democratize medical evidence,” said Dr.Evidence CEO Bob Battista, MBA, FRSPH, FRCP Edinburgh. “That starts with getting medical evidence into the hands of physicians and HCPs who interact daily with peers and directly with patients. Combining the power of the MedShr docsearch specialized medical search engine with the expansive reach of MedShr’s HCP-facing platform creates an unprecedented opportunity for putting actionable insights into the hands of physicians and HCPs, and, in turn, helping them deliver better, evidence-based patient care.”  

About MedShr™

MedShr is the world’s leading case discussion platform, connecting nearly two million doctors across 195 countries and supporting digital medical education for hundreds of national and specialist medical societies. In addition to the Trinity Challenge, MedShr has won multiple awards for technology, business and impact including Facebook’s Social Good App of the Year 2016, United Nations World Summit Award 2017, ES SME Award in 2018, London Business Award 2020, and Pharma Marketing Award 2021.  

About Dr.Evidence™ 

Dr.Evidence™ is the leading medical intelligence platform for life sciences companies that enables teams to identify breakthrough insights grounded in the vast universe of published medical information, real-world evidence and proprietary data. It pushes the boundaries of healthcare technology and allows for new possibilities in science, enabling more informed decision-making and faster time-to-market for accelerated impact. 

Share this:

Like this:

Like Loading...
%d bloggers like this: